Corinne Seng Yue
Research Subjects
Corinne Seng Yue has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Armin Schüler
Global Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany
1 shared publication Claudia Scarsi
Doctor of Pharmacy, IBSA Institut Biochimique SA
1 shared publicationEleanor Harrison-Moench
Merck Healthcare, Quantitat Pharmacol, Darmstadt, Germany
1 shared publicationElisa Bettazzi
Master of Science, IBSA Institut Biochimique SA
1 shared publicationEmmanuelle Vincent
Fresenius Kabi SwissBioS, Biosimilars, Eysins, Switzerland
1 shared publicationFrancesco S. Celi
Doctor of Medicine, Master of Health Science, Department of Medicine at University of Connecticut Health
1 shared publication
Latest Publications
- Open Access
- 28 March 2024
- Published by Elsevier in Endocrine Practice
- Vol. 30 (6) , 513-520
Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine
- 28 March 2024
- Published by Elsevier in Endocrine Practice
- Vol. 30 (6) , 513-520
Open AccessProton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine
- Open Access
- 1 August 2020
- Published by Elsevier in Clinical Therapeutics
- Vol. 42 (8) , 1508-1518.e1
Pharmacokinetics and Pharmacodynamics of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta in Healthy Subjects: A Randomized, Double-blind Trial
- 1 August 2020
- Published by Elsevier in Clinical Therapeutics
- Vol. 42 (8) , 1508-1518.e1
Open AccessPharmacokinetics and Pharmacodynamics of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta in Healthy Subjects: A Randomized, Double-blind Trial
- 8 August 2011
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 49 (7) , 659-663
Aluminum toxicokinetics in peritoneal dialysis patients
Context. Despite the risk of aluminum (Al) toxicity in dialysis patients, little is known about its toxicokinetics (TK) in this population. A national contamination of dialysate solutions with Al provided the opportunity to study Al TK in peritoneal dialysis (PD) patients and to better understand the influence of covariates on its disposition. Methods. Al levels in serum and dialysate as well as other laboratory values were collected prospectively from 83 PD patients after correction of Al contamination. Population TK analyses were conducted with NONMEM VI using standard model discrimination criteria. Covariate analyses were also performed using stepwise forward regression followed by backward deletion. Results. After correction of Al exposure, serum levels declined in a biphasic manner, which was captured by the TK model. The TK of Al were best described by a 2-compartment model with linear elimination. Total creatinine clearance was a significant covariate for total clearance (CL). Mean parameter estimates for volume of central compartment (V1), CL, volume of peripheral compartment (V2), volume of distribution at steady-state (Vss), and intercompartmental clearance (Q) were 168 L, 8.99 L/day, 12 000 L, 12 168 L, and 4.93 L/day, respectively. Inter-individual variability for CL and V2 were 22.6 and 51.1%, respectively. Al distributional half-life was 8.5 days, while the terminal elimination half-life was 7.2 years. This model confirms that the large Vss reflects the widespread distribution of Al in bone, lungs, liver, and other tissues. Conclusion. This study describes the first population Al TK model in a large group of PD patients, which includes a covariate effect. The model confirms the extensive half-life and tissue distribution of Al in a dialysis-dependent population.
- 8 August 2011
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 49 (7) , 659-663
Aluminum toxicokinetics in peritoneal dialysis patients
Context. Despite the risk of aluminum (Al) toxicity in dialysis patients, little is known about its toxicokinetics (TK) in this population. A national contamination of dialysate solutions with Al provided the opportunity to study Al TK in peritoneal dialysis (PD) patients and to better understand the influence of covariates on its disposition. Methods. Al levels in serum and dialysate as well as other laboratory values were collected prospectively from 83 PD patients after correction of Al contamination. Population TK analyses were conducted with NONMEM VI using standard model discrimination criteria. Covariate analyses were also performed using stepwise forward regression followed by backward deletion. Results. After correction of Al exposure, serum levels declined in a biphasic manner, which was captured by the TK model. The TK of Al were best described by a 2-compartment model with linear elimination. Total creatinine clearance was a significant covariate for total clearance (CL). Mean parameter estimates for volume of central compartment (V1), CL, volume of peripheral compartment (V2), volume of distribution at steady-state (Vss), and intercompartmental clearance (Q) were 168 L, 8.99 L/day, 12 000 L, 12 168 L, and 4.93 L/day, respectively. Inter-individual variability for CL and V2 were 22.6 and 51.1%, respectively. Al distributional half-life was 8.5 days, while the terminal elimination half-life was 7.2 years. This model confirms that the large Vss reflects the widespread distribution of Al in bone, lungs, liver, and other tissues. Conclusion. This study describes the first population Al TK model in a large group of PD patients, which includes a covariate effect. The model confirms the extensive half-life and tissue distribution of Al in a dialysis-dependent population.